Status:
COMPLETED
Dilute Betadine Lavage in the Prevention of Postoperative Infection
Lead Sponsor:
Rush University Medical Center
Collaborating Sponsors:
Central DuPage Hospital
Conditions:
Prosthesis-Related Infections
Arthroplasty
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to examine the efficacy of a dilute betadine solution in reducing infectious complications in revision total knee arthroplasty. The investigators will enroll patients who ...
Detailed Description
Infections in total knee arthroplasty are still a major source of morbidity and mortality in Orthopaedics. They often necessitate long term antibiotics, reoperation, and can lead to further complicati...
Eligibility Criteria
Inclusion
- Scheduled to undergo revision total knee arthroplasty
Exclusion
- Inability to provide informed consent or to comply with study assessments (e.g. due to cognitive impairment or geographic distance).
- Age ≤ 17.
- Allergy to povidone iodine.
- Any condition requiring antibiotics 14 days prior to arriving for surgery.
- Patients with chronic immunosuppression (such as HIV/AIDS).
- Unable to adhere to follow up schedule and treatment.
- Patients scheduled to undergo revision total knee arthroplasty for infectious reasons.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 8 2019
Estimated Enrollment :
505 Patients enrolled
Trial Details
Trial ID
NCT01175044
Start Date
August 1 2010
End Date
July 8 2019
Last Update
August 17 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612
2
Central DuPage Hospital
Winfield, Illinois, United States, 60190